Plasminogen Activator Inhibitor Type 1 Is Increased in the Arterial Wall of Type II Diabetic Subjects

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2001-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HQ0801.093667PMID 11498469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

  2000cited by this paper
• Diabetes mellitus induces decreased plasma fibrinolytic activity and increased tissue synthesis of plasminogen activator inhibitor-1 (PAI-1) in the rat

  2000cited by this paper
• Plasminogen-activator inhibitor type 1 and coronary artery disease.

  2000cited by this paper
• Diabetes and cardiovascular disease

  2000cited by this paper
• Diabetes and cardiovascular disease.

  1999cited by this paper
• Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox.

  1999cited by this paper
• Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

  1999cited by this paper
• Sp1 Sites Mediate Activation of the Plasminogen Activator Inhibitor-1 Promoter by Glucose in Vascular Smooth Muscle Cells*

  1998cited by this paper
• Fibrinolysis and atherogenesis in the JCR:LA-cp rat in relation to insulin and triglyceride concentrations in blood

  1998cited by this paper
• Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.

  1998cited by this paper
• Effects of lipids and lipoproteins on thrombosis and rheology.

  1998cited by this paper
• PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events

  1997cited by this paper
• Influence of Metabolic Control on Thromboxane Biosynthesis and Plasma Plasminogen Activator Inhibitor Type-1 in Non-insulin-dependent Diabetes mellitus

  1996cited by this paper
• Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus.

  1996cited by this paper
• Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture

  1996cited by this paper
• Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.

  1994cited by this paper
• Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction.

  1993cited by this paper
• Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis.

  1993cited by this paper
• Increased Expression of Tissue Plasminogen Activator and Its Inhibitor and Reduced Fibrinolytic Potential of Human Endothelial Cells Cultured in Elevated Glucose

  1992cited by this paper
• Evolving natural history of coronary artery disease in diabetes mellitus.

  1991cited by this paper
• Glycometabolic control and fibrinolysis in diabetic patients.

  1991cited by this paper
• Glycometabolic control and fibrinolysis in diabetic patients.

  1990cited by this paper
• 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.

  1990cited by this paper
• Tissue-type plasminogen activator release in response to epinephrine in perfused rat hindlegs.

  1989cited by this paper
• Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.

  1988cited by this paper
• Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

  1987cited by this paper
• Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects.

  1986cited by this paper
• Factors of the hemostatic system in diabetic patients. A survey of controlled studies.

  1986cited by this paper
• Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

  1985cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper

• Why Are Internal Mammary (Thoracic) Arteries Less Prone to Developing Atherosclerosis Compared to Coronary Arteries? Do Gut Microbiota Play a Role? A Narrative Review

  2025cites this paper
• Impact of dairy intake on circulating fatty acids and associations with blood pressure: A randomized crossover trial.

  2025cites this paper
• Comparison of the cardioprotective effects of liraglutide, dapagliflozin and their combination in a rat model of diabetes induced by streptozotocin.

  2025cites this paper
• HOMA-IR as a Predictor of PAI-1 Levels in Women with Severe Obesity

  2024cites this paper
• Novel therapeutic activities of dragon blood from palm tree Daemonorops draco for the treatment of chronic diabetic wounds

  2024cites this paper
• Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus

  2024cites this paper
• Roles of Plasminogen Activator Inhibitor-1 in Heterotopic Ossification Induced by Achilles Tenotomy in Thermal Injured Mice

  2024cites this paper
• Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population

  2024cites this paper
• PAI-1 Regulates the Cytoskeleton and Intrinsic Stiffness of Vascular Smooth Muscle Cells

  2024cites this paper
• The role of fibrinolysis in the development of prediabetes-associated coronary heart disease: a focus on the plasminogen activator inhibitor -1 and its potential use as a predictive marker in diet-induced prediabetes

  2023cites this paper
• Polycystic ovary syndrome: Causes, symptoms, pathophysiology, and remedies

  2023cites this paper
• Lack of Change in Blood Pressure and Arterial Stiffness after High Dairy Intake in Hyperinsulinemic Subjects: A Cross-Over Randomized Controlled Trial.

  2023cites this paper
• Evaluating the effect of antidiabetic treatment on haemostatic and fibrinolytic parameters among type 2 diabetics in Ilorin, Nigeria

  2022cites this paper
• Fibrinolysis Regulation: A Promising Approach to Promote Osteogenesis

  2022cites this paper
• Changes of new coagulation markers in healthy pregnant women and establishment of reference intervals in Changsha.

  2022cites this paper
• PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?

  2022cites this paper
• The mechanisms of glycolipid metabolism disorder on vascular injury in type 2 diabetes

  2022cites this paper
• Some fibrinolytic parameters in coronary artery disease patients: focus on unstable angina subgroups

  2021cites this paper
• Association of Plasminogen Activator Inhibitor-1 and Cardiovascular Events Development in Patients with Prediabetes

  2021cites this paper
• Clinical outcomes of patients with diabetes mellitus and acute ST-elevation myocardial infarction following fibrinolytic therapy: a nationwide inpatient sample (NIS) database analysis

  2021cites this paper
• Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor

  2020cites this paper
• Diabetes and the Cardiovascular System

  2020cites this paper
• Fibrosis and diabetes: Chronic hyperglycemia triggers organ-specific fibrotic mechanisms

  2020cites this paper
• Fetuin-B regulates vascular plaque rupture via TGF-β receptor-mediated Smad pathway in vascular smooth muscle cells

  2020cites this paper
• Thrombolysis Outcomes in Patients with Diabetes and Previous Stroke: A Meta-Analysis

  2020cites this paper
• Diet and postprandial risk markers for complications in type 2 diabetes

  2020cites this paper
• Predicting parenchymal hematoma associated with endovascular thrombectomy for acute occlusion of anterior circulation large vessel: the GuEss-MALiGn scale

  2020influential citation
• Circulating miR-30c as a predictive biomarker of type 2 diabetes mellitus with coronary heart disease by regulating PAI-1/VN interactions.

  2019cites this paper
• Arterial Aging and Age-Associated Arterial Diseases

  2019influential citation
• The ameliorating effect of carotenoid rich fraction extracted from Dunaliella salina microalga against inflammation- associated cardiac dysfunction in obese rats

  2019cites this paper
• DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome

  2019cites this paper
• Therapeutic Options Targeting Oxidative Stress, Mitochondrial Dysfunction and Inflammation to Hinder the Progression of Vascular Complications of Diabetes

  2019cites this paper
• Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor‐1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans

  2018cites this paper
• Nicotine exposure suppresses hyperinsulinemia and improves endothelial dysfunction mediators independent of corticosteroids in insulin-resistant oral contraceptive-treated female rats

  2018cites this paper
• Changes in spontaneous thrombolytic activity during progression of atherosclerosis in Apo-/- and LDLR-/- double knockout mice.

  2018cites this paper
• Plasminogen activator inhibitor‐1 regulates the vascular expression of vitronectin

  2017cites this paper
• Implication of Free Fatty Acids in Thrombin Generation and Fibrinolysis in Vascular Inflammation in Zucker Rats and Evolution with Aging

  2017influential citation
• The role of Toxoplasma gondii as a possible inflammatory agent in the pathogenesis of type 2 diabetes mellitus in humans

  2016cites this paper
• PROGNOSTIC VALUE OF BLOOD GLUCOSE LEVELS IN DIABETIC PATIENTS UPON ADMISSION AND ITS OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME

  2016cites this paper
• Biomarkers of cerebral atherosclerosis: The potential for early diagnosis and individual risk prognosis

  2016cites this paper
• Hyperglycaemia in acute intracerebral haemorrhage

  2016cites this paper
• Rôle des cellules musculaires lisses vasculaires et des intégrines dans la génération de thrombine dans le compartiment sanguin et vasculaire

  2016influential citation
• Post thrombolytic resolution of ST elevation in STEMI patients

  2016cites this paper
• Fructose induces prothrombotic phenotype in human endothelial cells

  2015cites this paper
• Arteriosclerosis, Thrombosis, and Vascular Biology.

  2015cites this paper
• Plasminogen Activator Inhibitor-1 Inhibits Angiogenic Signaling by Uncoupling Vascular Endothelial Growth Factor Receptor-2-&agr;V&bgr;3 Integrin Cross Talk

  2015cites this paper
• Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity

  2015cites this paper
• Serpine1 Mediates Porphyromonas gingivalis Induced Insulin Secretion in the Pancreatic Beta Cell Line MIN6.

  2015cites this paper
• Fibroblast growth factor-2 did not restore plasminogen system activity in endothelial cells on glycated collagen

  2015cites this paper
• Pathogenesis of diabetic cerebral vascular disease complication.

  2015cites this paper
• Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification.

  2015cites this paper
• Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification.

  2015cites this paper
• Enfermedad coronaria multivaso, disfunción endotelial y angioplastia en la diabetes mellitus. A propósito de un caso

  2014cites this paper
• The Injurious Effects of Hyperinsulinism on Blood Vessels

  2014cites this paper
• The growth factor effect on endothelial cell dysfunction in the presence of glycated collagen and Abeta peptide: implications for decreased angiogenesis in diabetes and Alzheimer's disease

  2014cites this paper
• Multivessel coronary artery disease , angioplasty and endothelial dysfunction in diabetes mellitus . Case Report

  2014cites this paper
• Prévention de l'insuffisance cardiaque par l'antagonisation du récepteur des minéralocorticoïdes dans un contexte de syndrome métabolique : une étude intégrative du phénome, du transcriptiome et du miRNOme

  2014cites this paper
• The operating surgeon is an independent predictor of chest tube drainage following cardiac surgery.

  2014cites this paper
• Functional Stability of Plasminogen Activator Inhibitor-1

  2014cites this paper
• Role of Plasminogen Activator Inhibitor-1 in Senescence and Aging

  2014cites this paper
• Plasminogen activator inhibitor-1 inhibitors: a patent review (2006 – present)

  2013cites this paper
• Effects of pioglitazone and vildagliptin on coagulation cascade in diabetes mellitus – targeting thrombogenesis

  2013cites this paper
• Medical Management and Strategies to Prevent Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus

  2013cites this paper
• Diabetic patients with multivessel coronary disease treated by percutaneous coronary intervention

  2013cites this paper
• Humoral response towards high density lipoprotein : a new mechanism for atherogenesis

  2013cites this paper
• Pathophysiology of post-stroke hyperglycaemia and brain arterial patency

  2013cites this paper
• Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.

  2013cites this paper
• Explicit Consideration of Baseline Factors to Assess Recombinant Tissue-Type Plasminogen Activator Response With Respect to Race and Sex

  2013cites this paper
• Pacientes diabéticos con enfermedad coronaria multivaso tratados mediante intervencionismo coronario percutáneo

  2013cites this paper
• Management of the patient with diabetes and coronary artery disease: a contemporary review.

  2013cites this paper
• Hypertension, hypercoagulability and the metabolic syndrome: A cluster of risk factors for cardiovascular disease

  2012cites this paper
• Cardiometabolic aspects of the polycystic ovary syndrome.

  2012cites this paper
• PAI-1 and Diabetes: A Journey From the Bench to the Bedside

  2012cites this paper
• Étude de l'implication des cellules musculaires lisses vasculaires dans la distensibilité et le phénotype thrombotique dans des modèles murins

  2012cites this paper
• Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model.

  2012cites this paper
• Therapy: Part I Diabetes and Vascular Disease : Pathophysiology, Clinical Consequences, and Medical

  2012cites this paper
• Histopathology and histomorphometry of umbilical cord blood vessels. Findings in normal and high risk pregnancies

  2011cites this paper
• Pioglitazone suppresses advanced glycation end product-induced expression of plasminogen activator inhibitor-1 in vascular smooth muscle cells.

  2011cites this paper
• Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells

  2011cites this paper
• Multifaceted Role of Plasminogen Activator Inhibitor-1 in Regulating Early Remodeling of Vein Bypass Grafts

  2011cites this paper
• DIABETIC STUDIES The Review of Effects of Different Protein Sources on Plasminogen Inhibitor-1 and Factor VII Coagulant Activity Added to a Fat-Rich Meal in Type 2 Diabetes

  2011cites this paper
• The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury

  2011cites this paper
• Critical Role of the Nitric Oxide/Reactive Oxygen Species Balance in Endothelial Progenitor Dysfunction

  2011cites this paper
• PAI-1 antagonists: the promise and the peril.

  2011cites this paper
• The Prevention of Atherothrombotic Events in Adults with Acute Coronary Syndromes

  2011cites this paper
• Diabetes Mellitus and Cardiovascular Disease

  2011cites this paper
• ROLE OF OXIDATIVE STRESS IPATHOGEESIS OF DIABETES AD ITS COMPLICATIOS

  2011cites this paper
• ROLE OF OXIDATIVE STRESS I PATHOGE ESIS OF DIABETES A D ITS COMPLICATIO S

  2011cites this paper
• The association of diabetes mellitus with the severity of angiographic findings in patients with newly-diagnosed coronary artery disease

  2011cites this paper
• 5(684-692) EMM 079(11058).hwp

  2011cites this paper
• Effects of different protein sources on plasminogen inhibitor-1 and factor VII coagulant activity added to a fat-rich meal in type 2 diabetes.

  2010cites this paper
• Pathophysiology of the proatherothrombotic state in the metabolic syndrome.

  2010cites this paper
• Diabetes mellitus and sudden cardiac death: what are the data?

  2010cites this paper
• Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells.

  2010cites this paper
• Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.

  2010cites this paper
• Upstream stimulatory factor‐2 mediates quercetin‐induced suppression of PAI‐1 gene expression in human endothelial cells

  2010cites this paper
• Plasminogen activator inhibitor‐1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices

  2010cites this paper
• Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment.

  2010cites this paper
• The prognostic value of blood glucose level on admission in non-diabetic patients with acute myocardial infarction

  2009cites this paper
• Biological mechanisms of stroke prevention by physical activity in type 2 diabetes

  2009cites this paper